Oncocyte Corp. Files SEC Form S-3/A, Registration Statement Under Securities Act of 1933: (May 17, 2024).
In: Health & Medicine Week, 2024-06-07, S. 10514-10514
serialPeriodical
Zugriff:
Oncocyte Corp., a healthcare biotechnology company, has filed a Form S-3/A with the U.S. Securities and Exchange Commission (SEC). The filing, made on May 17, 2024, is a formal document or financial statement submitted by publicly-traded companies. The SEC file number for this filing is 0001493152-24-020480. The company's contact information is located in Irvine, CA. For more information on this filing, please visit the SEC's website. [Extracted from the article]
Copyright of Health & Medicine Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Oncocyte Corp. Files SEC Form S-3/A, Registration Statement Under Securities Act of 1933: (May 17, 2024).
|
---|---|
Zeitschrift: | Health & Medicine Week, 2024-06-07, S. 10514-10514 |
Veröffentlichung: | 2024 |
Medientyp: | serialPeriodical |
ISSN: | 1531-6459 (print) |
Sonstiges: |
|